Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Relief Therapeutics Holding AG    RLF   CH0100191136

RELIEF THERAPEUTICS HOLDING AG

(RLF)
  Report
SummaryQuotesChartsNewsCompanyFinancials 
 SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news
Most relevant news about RELIEF THERAPEUTICS HOLDING AG
10:14aNEURORX AND RELIEF ANNOUNCE INITIAL : 72% survival seen in ICU patients
PR
01:17aNEURORX AND RELIEF ANNOUNCE INITIAL : 72% survival seen in ICU patients
PU
01:14aNEURORX AND RELIEF ANNOUNCE INITIAL : 72% survival seen in ICU patients
EQ
11/23RELIEF THERAPEUTICS : Announces Notice of Extraordinary General Meeting of THERA..
PU
11/23RELIEF THERAPEUTICS : Announces Notice of Extraordinary General Meeting of THERA..
EQ
11/18RELIEF THERAPEUTICS : Selects CRO and CDMO for RLF-100TM in Europe
PU
11/18RELIEF THERAPEUTICS : Selects CRO and CDMO for RLF-100TM in Europe
EQ
11/13NEURORX : and Relief Therapeutics announce enrollment of 150 patients in phase 2..
PR
11/13RELIEF THERAPEUTICS : with Partner NeuroRx, Announces Enrollment of 150 Patients..
PU
11/13RELIEF THERAPEUTICS : with Partner NeuroRx, Announces Enrollment of 150 Patients..
EQ
11/05RELIEF THERAPEUTICS : pushes back data release date for COVID-19 study to Januar..
RE
11/05RELIEF THERAPEUTICS AND NEURORX ANNO : Trial is on track to complete enrollment ..
PU
11/05NEURORX AND RELIEF THERAPEUTICS ANNO : Trial is on track to complete enrollment ..
PR
11/05RELIEF THERAPEUTICS AND NEURORX ANNO : Trial is on track to complete enrollment ..
EQ
11/04RELIEF THERAPEUTICS : Appoints J. Paul Waymack, M.D., Sc.D. as Consultant to Str..
PU
More most relevant news
All news about RELIEF THERAPEUTICS HOLDING AG
10:14aNEURORX AND RELIEF ANNOUNCE INITIAL : 72% survival seen in ICU patients
PR
01:17aNEURORX AND RELIEF ANNOUNCE INITIAL : 72% survival seen in ICU patients
PU
01:14aNEURORX AND RELIEF ANNOUNCE INITIAL : 72% survival seen in ICU patients
EQ
11/23RELIEF THERAPEUTICS : Announces Notice of Extraordinary General Meeting of THERA..
PU
11/23RELIEF THERAPEUTICS : Announces Notice of Extraordinary General Meeting of THERA..
EQ
11/18RELIEF THERAPEUTICS : Selects CRO and CDMO for RLF-100TM in Europe
PU
11/18RELIEF THERAPEUTICS : Selects CRO and CDMO for RLF-100TM in Europe
EQ
11/13NEURORX : and Relief Therapeutics announce enrollment of 150 patients in phase 2..
PR
11/13RELIEF THERAPEUTICS : with Partner NeuroRx, Announces Enrollment of 150 Patients..
PU
11/13RELIEF THERAPEUTICS : with Partner NeuroRx, Announces Enrollment of 150 Patients..
EQ
More news
News in other languages on RELIEF THERAPEUTICS HOLDING AG
05:31aBourse Zurich: le SMI cède l'intégralité de ses gains initiaux
05:31aAktien Schweiz: SMI dreht leicht in Minus - Sektorrotation geht weiter
03:36aAktien Schweiz Eröffnung: Fester nach Aufgabe der Blockadehaltung durch Trump
02:46aBourse Zurich: ouverture attendue en hausse sous le double effet vaccin+Trump
02:42aMorning Briefing - Markt Schweiz
02:16aRelief revendique un succès d'étape contre le Covid-19 sévère
01:56aRelief-Kandidat RLF-100 zeigt gute Resultate in Corona-Nachbehandlung
01:14aNEURORX UND RELIEF VERÖFFENTLICHEN E : 72% Überlebensrate bei Intensivpatienten
01:13aNEURORX UND RELIEF VERÖFFENTLICHEN E : 72% Überlebensrate bei Intensivpatienten
11/23Aktien Schweiz: Uneinheitlich - Zwischen Corona-Hoffnung und Konjunktursorge
Press releases
10:14aNEURORX AND RELIEF ANNOUNCE INITIAL : 72% survival seen in ICU patients
PR
01:17aNEURORX AND RELIEF ANNOUNCE INITIAL : 72% survival seen in ICU patients
PU
01:14aNEURORX AND RELIEF ANNOUNCE INITIAL : 72% survival seen in ICU patients
EQ
11/23RELIEF THERAPEUTICS : Announces Notice of Extraordinary General Meeting of THERA..
PU
11/23RELIEF THERAPEUTICS : Announces Notice of Extraordinary General Meeting of THERA..
EQ
More press releases